Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (4074)	4/16/1998 1:47:00 PM
From: billkirn	Read Replies (3) of 6136

Steve: A negative sentiment is developing because of the high expectations over the last few years. This will change over time as Agouron's products become more visible and they develop some better business partnerships. I don't think it will change in time to save my options. It is unfortunate Peter has not been able to establish some good partnerships after leaving the exceptional deal with Roche. I think the added risk of going it alone will keep a negative cloud over the company, especially since we are witnessing huge mergers taking place in this industry. It looks pretty dark right now, but sentiment can turn at any moment. I think we need to trust Agouron's team. They really have done an exceptional job so far and I'll bet on the future with them. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next